Privi Speciality Chemicals Ltd
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]
- Market Cap ₹ 7,452 Cr.
- Current Price ₹ 1,908
- High / Low ₹ 2,030 / 1,031
- Stock P/E 49.2
- Book Value ₹ 254
- Dividend Yield 0.10 %
- ROCE 11.8 %
- ROE 10.5 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 7.52 times its book value
- The company has delivered a poor sales growth of 5.49% over past five years.
- Company has a low return on equity of 8.41% over last 3 years.
- Dividend payout has been low at 5.42% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Allcap BSE Commodities BSE SmallCap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|
597 | 1,024 | 1,341 | 1,324 | 1,277 | 1,404 | 1,608 | 1,752 | 1,972 | |
525 | 894 | 1,128 | 1,104 | 1,067 | 1,209 | 1,420 | 1,423 | 1,564 | |
Operating Profit | 72 | 130 | 213 | 221 | 210 | 195 | 188 | 329 | 408 |
OPM % | 12% | 13% | 16% | 17% | 16% | 14% | 12% | 19% | 21% |
10 | 16 | 14 | 66 | 43 | 38 | 21 | 26 | 17 | |
Interest | 20 | 24 | 29 | 38 | 24 | 25 | 70 | 102 | 90 |
Depreciation | 27 | 43 | 47 | 57 | 71 | 75 | 108 | 123 | 126 |
Profit before tax | 36 | 79 | 152 | 193 | 158 | 133 | 31 | 130 | 209 |
Tax % | 24% | 32% | 38% | 24% | 26% | 27% | 31% | 27% | |
27 | 53 | 94 | 146 | 117 | 97 | 21 | 95 | 153 | |
EPS in Rs | 7.21 | 14.19 | 24.10 | 37.35 | 29.90 | 24.91 | 5.68 | 24.27 | 38.74 |
Dividend Payout % | 14% | 11% | 10% | 4% | 7% | 8% | 0% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 11% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | -3% |
TTM: | 204% |
Stock Price CAGR | |
---|---|
10 Years: | 22% |
5 Years: | 39% |
3 Years: | -2% |
1 Year: | 63% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 8% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 38 | 38 | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
Reserves | 406 | 451 | 537 | 573 | 683 | 773 | 790 | 885 | 953 |
321 | 330 | 491 | 510 | 538 | 933 | 1,079 | 1,008 | 1,053 | |
174 | 235 | 359 | 262 | 280 | 431 | 483 | 410 | 412 | |
Total Liabilities | 939 | 1,053 | 1,426 | 1,384 | 1,540 | 2,176 | 2,391 | 2,343 | 2,457 |
388 | 437 | 498 | 598 | 598 | 704 | 1,017 | 1,034 | 981 | |
CWIP | 24 | 49 | 95 | 30 | 175 | 373 | 100 | 99 | 233 |
Investments | 1 | 3 | 0 | 1 | 0 | 12 | 7 | 40 | 9 |
527 | 564 | 833 | 754 | 768 | 1,087 | 1,268 | 1,169 | 1,235 | |
Total Assets | 939 | 1,053 | 1,426 | 1,384 | 1,540 | 2,176 | 2,391 | 2,343 | 2,457 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
17 | 107 | 21 | 216 | 149 | 5 | 49 | 354 | |
80 | -81 | -139 | -176 | -242 | -321 | -133 | -180 | |
-89 | -20 | 122 | 28 | 23 | 333 | 72 | -171 | |
Net Cash Flow | 7 | 5 | 4 | 68 | -69 | 17 | -12 | 4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 106 | 82 | 90 | 63 | 68 | 69 | 67 | 72 |
Inventory Days | 236 | 132 | 162 | 152 | 170 | 279 | 311 | 245 |
Days Payable | 115 | 85 | 95 | 69 | 83 | 138 | 114 | 105 |
Cash Conversion Cycle | 227 | 129 | 157 | 146 | 155 | 209 | 264 | 212 |
Working Capital Days | 162 | 97 | 117 | 105 | 123 | 159 | 166 | 151 |
ROCE % | 13% | 18% | 17% | 13% | 10% | 6% | 12% |
Documents
Announcements
-
Board Meeting Intimation for Intimation Of Board Meeting
1d - Board meeting on May 3, 2025, to approve FY25 results and consider final dividend declaration.
-
Announcement Under Regulation 30 Of The SEBI (LODR),2015-Update Of State Incentives
8 Apr - Maharashtra government sanctions industrial promotion subsidy of 262.96 lakhs.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
4 Apr - Of Schedule of Analyst/Institutional Investor Meet to be held at the manufacturing facilities at Mahad on April 09,2025.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
31 Mar - Resignation of Mr. Khilnani and Mrs. Thakur as directors.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024TranscriptPPTREC
-
Nov 2023TranscriptPPTREC
-
Aug 2023TranscriptNotesPPTREC
-
Aug 2023TranscriptNotesPPTREC
-
Jun 2023TranscriptNotesPPTREC
-
Feb 2023TranscriptNotesPPT
-
May 2022TranscriptPPT
-
Jan 2022Transcript PPT
-
Jul 2017TranscriptNotesPPT
-
Jul 2016TranscriptNotesPPT
-
Nov 2011TranscriptPPT
Business Profile[1]
Privi Speciality Chemicals Limited, formerly Fairchem Speciality Limited, is India’s largest manufacturer and exporter of aroma chemicals, holding a >20% global market share in ten products. The company specializes in manufacturing, supplying, and exporting bulk aroma and fragrance chemicals.[2]